Journal
SCIENCE CHINA-CHEMISTRY
Volume 63, Issue 6, Pages 766-770Publisher
SCIENCE PRESS
DOI: 10.1007/s11426-019-9685-6
Keywords
NIR-II; orthotopic osteosarcoma; imaging
Categories
Funding
- National Natural Science Foundation of China [81773674, 21473041, 81573383]
- Natural Science Foundation of Hubei Province [2017CFB711, 2017CFA024, 2016ACA126]
- Fundamental Research Funds for the Central Universities
- Tibet Autonomous Region Science and Technology Plan Project Key Project [XZ201901-GB-11]
- Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology [2019020701011429]
- Chengdu University of Traditional Chinese Medicine [CZYJC1903]
- Health Commission of Hubei Province Scientific Research Project [WJ2019M178, WJ2019M177]
Ask authors/readers for more resources
Osteosarcoma is the most common primary malignant tumor of bone, particularly among children and adolescents. Advances in imaging, surgical techniques, and implants have dramatically reduced the need for amputation in the past three decades. Recently, in vivo fluorescence imaging in the second near-infrared window (NIR-II, 1,000-1,700 nm) shows impressive advantages of deeper tissue penetration and higher spatial resolution, which makes it a promising tool for the early diagnosis and post-operative observation of Osteosarcoma. To the best of our knowledge, this paper is the first time to develop a novel NIR-II fluorescence probe conjugated with an osteosarcoma targeted oligopeptide for molecular tumor imaging in a xenograft orthotopic osteosarcoma mouse model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available